Colgate-Palmolive (NYSE:CL) Price Target Cut to $100.00 by Analysts at TD Cowen

Colgate-Palmolive (NYSE:CL) had its price target lowered by stock analysts at TD Cowen from $110.00 to $100.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. TD Cowen’s target price indicates a potential upside of 14.68% from the company’s previous close.

A number of other brokerages also recently weighed in on CL. JPMorgan Chase & Co. lifted their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price objective for the company from $105.00 to $101.00 in a research note on Monday, October 28th. Piper Sandler decreased their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday. Wells Fargo & Company cut their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday. Finally, StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Wednesday, January 1st. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $103.63.

Colgate-Palmolive Price Performance

CL traded down $0.19 on Wednesday, reaching $87.20. The stock had a trading volume of 1,428,512 shares, compared to its average volume of 3,702,811. The firm has a 50-day moving average of $93.03 and a 200-day moving average of $98.31. The company has a market capitalization of $71.24 billion, a price-to-earnings ratio of 24.99, a price-to-earnings-growth ratio of 3.31 and a beta of 0.44. Colgate-Palmolive has a fifty-two week low of $79.69 and a fifty-two week high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.

Insider Activity at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.34% of the stock is owned by insiders.

Institutional Trading of Colgate-Palmolive

Several large investors have recently modified their holdings of the business. D Orazio & Associates Inc. raised its stake in Colgate-Palmolive by 3.9% in the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after buying an additional 108 shares in the last quarter. Fiducient Advisors LLC lifted its position in Colgate-Palmolive by 5.2% during the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after acquiring an additional 110 shares during the period. Wealthspire Advisors LLC boosted its stake in Colgate-Palmolive by 3.0% during the second quarter. Wealthspire Advisors LLC now owns 3,853 shares of the company’s stock worth $374,000 after acquiring an additional 111 shares in the last quarter. Sequoia Financial Advisors LLC grew its holdings in Colgate-Palmolive by 0.6% in the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after purchasing an additional 113 shares during the period. Finally, Evernest Financial Advisors LLC increased its stake in shares of Colgate-Palmolive by 4.0% during the second quarter. Evernest Financial Advisors LLC now owns 2,985 shares of the company’s stock valued at $290,000 after purchasing an additional 115 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.